Table 2.

Demographics GBM at First or Second Recurrence: Toca 511 and Toca FC vs. Lomustine External Control

Treatment Group	Toca 511&Toca FC (N=27)	Lomustine (N=84)
Characteristics	n (%)	n (%)
Sex
Female	4 (14.8)	33 (39.3)
Male	23 (85.2)	51 (60.7)
Age, years
Median	61	54
Range	41–71	18–75
Age, years
< 50	5 (18.5)	27 (32.1)
≥ 50	22 (81.5)	57 (67.9)
Karnofsky performance status
70–80	7 (25.9)	41 (48.8)
90–100	20 (74.1)	43 (51.2)
Time from diagnosis (months)
Median	11.6	11.5
Range	5.1–49.4	4.4–92.1
Recurrence
First	19 (70.4)	65 (77.4)
Second	8 (29.6)	19 (22.6)
Baseline Steroid Administration
Yes	23 (85.2)	46 (54.8)
No	4 (14.8)	38 (45.2)